CD Medical started by two partners who had the belief to take good established medical devices, innovate them and make them even more cost effective.
The first CD Medical product was Stericlens, the first bag in can sterile solution, used across the NHS and private sector.
Currently market leader in its category, Irripod has gone from strength to strength with its effective innovation and cost-efficiency.
Over time more innovative products have been added to the portfolio including:
- Stericlens – the first sterile ‘bag in can’ saline solution
- Peel-Easy – the first ‘bag in can’ adhesive remover spray
- Clinifilm Cream – the first emollient based silicon barrier cream
- Emollin – still the only spray application for 50:50 treatment in Eczema and dry skin
- Povitulle – delivering easy to open packaging for Povidone Iodine dressings.
CD Medical became part of the overall M&A Pharmachem, going from strength to strength in its core areas – Innovation and Cost Effectiveness. To maximise opportunities for both CD Medical and M&A Pharmachem the Senior Management team took the decision to separate the companies and allow them to flourish in their respective market place. Although collaboration is still integral to the success of both organisations, it has allowed both companies to focus on its core strengths.
As of 1st December 2015 CD Medical started to trade in its own right. With a committed senior management group, fully engaged sales team and vastly experienced head office support, CD Medical has the right foundations to grow from strength to strength.
CD Medical parted ways with M&A Pharmachem, allowing focus on the exciting potential of CD Medical independently.
This year, work has begun on a new company head quarters – a space for collaboration and development.
With a growing team, each member dedicated to supporting clinicians and improving the lives of their patients, 2022 looks to be an exciting year of progress.